Nivolumab trials for Metastatic Cutaneous Melanoma

All Nivolumab trials · All Metastatic Cutaneous Melanoma trials

Phase breakdown

Recruiting trials studying Nivolumab for Metastatic Cutaneous Melanoma

• A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
  NCT04511013 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 331 locations
• Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program
  NCT06265285 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer
  NCT05098210 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Time-of-Day Specified Immunotherapy for Advanced Melanoma, The TIME Trial
  NCT07155317 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations

Common questions

How many trials study Nivolumab for Metastatic Cutaneous Melanoma?

4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.